![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
CEO Martin Lehr discusses Context's clinical pipeline on The Big Biz Show. (Context Therapeutics) View |
![]() |
CEO Martin Lehr discusses Phase 1b/2 ELONA clinical trial The Big Biz Show that aired 2/2/23. (Context Therapeutics) View |
![]() |
2/21/23: CEO Martin Lehr discusses anticipated Q2 23 clinical updates on The Big Biz Show. (Context Therapeutics) View |
![]() |
Context Therapeutics reveals preclinical data from two pipeline programs (Proactive Investors) View |
![]() |
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers (Proactive Investors) View |
![]() |
Context Therapeutics - Collaborating to reshape women's cancer landscape (Edison) View |
![]() |
() View |
![]() |
() View |
![]() |
() View |
![]() |
() View |